Warby Parker Inc.

WRBY Healthcare Medical Instruments & Supplies

Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.

Revenue
+10.4%
EPS
−20.0%
Free cash flow
−30.3%

Quarter to September 2026, against a year earlier

26.05 4.76 +22.36%
Market cap
$3.2B
P/E
434×
Fwd P/E
208×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.64
Dividend safety
n/a

Warby Parker Inc. (WRBY) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Warby Parker Inc. (WRBY) trades at a EV/Sales of 3.2×. Over the past ten years it has ranged from 1.5× (November 2023) to 6.7× (November 2021); the current reading is higher than 70% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.7× (20.64%)
FY2024 3.4× 50.77%
FY2023 2.3× (4.88%)
FY2022 2.4× (57.51%)
FY2021 5.7× 2.84%
FY2020 5.5× 0.00%
FY2019 5.5× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.4× (10.65%)
Jun 2026 3.8× 46.48%
Mar 2026 2.6× (5.13%)
Dec 2025 2.7× (25.16%)
22 more quarters

Against its own ten years

Low 1.5× High 6.7×
Ten-year median 2.7×
Current reading's percentile 70

EV/Sales against peers

Company EV/Sales
XRAY DENTSPLY SIRONA Inc. compare 1.1×
ICUI ICU Medical, Inc. compare 2.3×
AZTA Azenta, Inc. compare 2.3×
STVN Stevanato Group S.p.A. compare 2.8×
WRBY Warby Parker Inc. 3.2×
ATRC AtriCure, Inc. compare 4.9×
LMAT LeMaitre Vascular, Inc. compare 6.2×
KMTS Kestra Medical Technologies, Ltd. compare 14.2×
PLSE Pulse Biosciences, Inc compare 2,578×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on WRBY